Full-Time
Provides diverse banking and financial services
No salary listed
Junior, Mid
Durham, NC, USA
Fifth Third Bank provides a variety of financial services to individual consumers, small businesses, and commercial clients. Its offerings include personal banking products like checking and savings accounts, mortgages, personal loans, and insurance options such as life and health coverage. For businesses, the bank offers services including business accounts, commercial loans, and treasury management. Fifth Third Bank's revenue comes from interest on loans, fees for account services, and commissions from insurance and wealth management services. The bank aims to help clients achieve their financial goals through comprehensive financial planning and investment advisory services.
Company Size
10,001+
Company Stage
IPO
Headquarters
Cincinnati, Ohio
Founded
1858
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Paid Sick Leave
Paid Holidays
Performance Bonus
Flexible Work Hours
Arevon Energy secured a $98 million tax equity commitment from Fifth Third Bank for its Ratts 1 and Heirloom Solar Projects in Indiana, adding 265 MW of energy. The projects, costing nearly $400 million, will contribute $86 million to local governments and employ 200 people. This marks Arevon's first tax equity partnership with Fifth Third Bank, leveraging the Inflation Reduction Act's tax credit transfer provision. Arevon has completed over $3.8 billion in project financings in 18 months.
/PRNewswire/ -- Mammoth Energy Services, Inc. (NASDAQ: TUSK) ("Mammoth" or the "Company") today announced that its subsidiary Lion Power Services LLC ("Lion")...
Global travel retailer WH Smith has announced the successful completion of a £200m issue of US Private Placement (USPP) notes and a bank term loan of £120m.
Corpay, Inc. (NYSE: CPAY), a global S&P 500 corporate payments company today announced that it successfully closed on an amendment to its Term Loa
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced today that it has closed on a $600 mil